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Graft arteriosclerosis is the major limitation to long-term survival
after heart transplantation. In this study, myocardial pathologic
changes, especially those that might permit early diagnosis, were
characterized in endomyocardial biopsy specimens and hearts
obtained at retransplantation or autopsy from nine orthotopic
heart transplant recipients. All had severe diffuse proliferative
arterial stenoses without plaque rupture or coronary thrombi.
Eight patients died with and one underwent retransplantation
because of graft arteriosclerosis <12 months (six patients) or >46
months (three patients) after operation. Six patients had anteced-
ent symptoms of congestive heart failure and six had angiograph-
ically demonstrated epicardial coronary artery graft arterioscle-
rosis; four had both.
Myocardial ischemic lesions included subendocardial myocyte
vacuolization (seven patients) and microfocal to regional coagula-
tion necrosis and granulation tissue or scar, or both (seven
patients). Subendocardial myocyte vacuolization (indicative of
The long-term survival of patients after orthotopic heart
transplantation (I) is limited by the development of obstruc-
tive coronary vascular lesions (graft arteriosclerosis) with
resultant ischemic myocardial injury (2-6). Accelerated graft
arteriosclerosis occurs in approximately 35% of such pa-
tients by 3 years after operation and in 50% by 5 years (4,5).
Graft arteriosclerosis is angiographically and pathologically
characterized by diffuse and concentric, usually noncompli-
cated, coronary obstructions that can involve intramyocar-
dial as well as epicardial coronary arteries (2,3,6). Moreover,
graft arteriosclerosis can develop and unpredictably become
significantly obstructive within months after transplantation.
The risk factors and pathogenesis are uncertain. Because
transplanted hearts are denervated, there are rarely any
early symptoms to alert physicians caring for such patients.
The myocardial injury associated with graft arterioscle-
rosis is usually recognized only by the functional conse-
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sublethal ischemic injury) was diagnosed at prior right ventricular
biopsy in two patients and was noted at autopsy in areas accessible
to right-sided biopsy in three additional patients. Three patients
had pathologic changes diagnostic of acute infarction on right or
left ventricular biopsy, or both. Thus, all nine patients had
lesions, of which five had biopsy-identified myocardial abnormal-
ities caused by graft arteriosclerosis.
It is concluded that graft arteriosclerosis yields not only
myocardial pathologic changes similar to those associated with
typical coronary atherosclerosis, but also lesions resulting from
focal or diffuse ischemia caused by small vessel obstructions. This
is manifest as subendocardial myocyte vacuolization or microfocal
infarction. Recognition of these biopsy-accessible myocardial
changes associated with graft arteriosclerosis may allow early
recognition and appropriate therapeutic intervention.
(J Am Coli CardioI1992;19:586-92)
quences of myocardial ischemia, namely, congestive heart
failure, arrhythmias and sudden death. The rapid onset and
symmetric and diffuse configuration of lesions and the insid-
ious progression of graft atherosclerosis render this compli-
cation of transplantation exceedingly difficult to diagnose
and manage. Thus, the mortality rate as a result of the
myocardial consequences of graft arteriosclerosis is high (7).
Percutaneous balloon angioplasty and aortocoronary bypass
grafting are generally not effective because of the involve-
ment of the distal epicardial and intramyocardial resistance
vessels. Retransplantation is the usual treatment of choice.
Nevertheless, early diagnosis by endomyocardial biopsy
would probably be helpful to select patients for closer
follow-up study and consideration for retransplantation or
occasionally revascularization or other therapy.
Although the arterial morphologic features of graft arte-
riosclerosis have been extensively studied (2,3,6), the asso-
ciated myocardial changes have not. Proliferative changes in
intramyocardial blood vessels (8) and subendocardial myo-
cyte vacuolization (9) have been suggested as markers of
graft arteriosclerosis. These pathologic changes are poten-
tially detectable by endomyocardial biopsy. Nevertheless,
the diagnostic considerations and pathologic description of
the different myocardial manifestations of graft arterioscle-
rosis have not been reported. Thus, we characterized the
pathologic features of the myocardium in nine cases of
0735-1097/92/$5.00
lACC Vol. 19. No.3
March I, 1992:586-92
NEISH ET AL.
MYOCARDIUM IN GRAFT ARTERIOSCLEROSIS
587
posttransplant graft arteriosclerosis in an attempt to define
those features that would facilitate early recognition in
endomyocardial biopsy samples.
Methods
Case selection. Nine cases of graft arteriosclerosis among
147 consecutive patients who underwent orthotopic heart
transplantation at the Brigham and Women's Hospital from
February 1984 to June 1991 were reviewed retrospectively.
In each of these cases, the cause of death (eight patients) or
indication for retransplantation (one patient) was attribut-
able to graft arteriosclerosis. In addition, severe graft arte-
riosclerosis was demonstrated by gross and histologic exam-
ination at autopsy or surgical pathologic examination in all
patients.
Morphologic studies. Endomyocardial biopsy specimens
and hearts were fixed in 10% neutral buffered formalin.
Endomyocardial biopsy specimens generally consisted of
three fragments removed from the right ventricle with a
Stanford bioptome with use of the standard right internal
jugular approach. In some cases, a left ventricular biopsy
was performed. The three most recent preterminal sets of
endomyocardial biopsy specimens from each case were
reviewed. Histologic sections of the whole hearts were taken
to include cross sections of the entire right and left ventric-
ular myocardium (7 to 10 sections) and multiple sections of
the coronary arteries, including proximal and distal epicar-
dial and intramyocardial vessels. Myocardial sections were
stained with hematoxylin-eosin and Masson's trichrome
stain (usually for collagen, but also to accentuate myocardial
coagulation necrosis). Sections of the coronary arteries
were also stained with the Verhoef-van Gieson stain for
elastin.
Myocardial sections were examined for evidence of isch-
emic injury and necrosis classified as follows: I) subendocar-
dial or periinfarct myocyte vacuolization (often called "my-
ocytolysis") (l0), 2) coagulation necrosis, 3) granulation
tissue, and 4) replacement fibrosis. Special attention was
paid to lesions in areas of myocardium accessible to endo-
myocardial biopsy (that is, the subendocardium of both the
right ventricular free wall and right ventricular aspect of the
interventricular septum).
Acute rejection. Acute rejection was scored on the scale
recently developed under the auspices of the International
Society for Heart Transplantation (lSHT) (lI). All patients
had a conventional regimen of immunosuppressive therapy,
consisting of cyclosporine A, prednisone and, in six of the
nine patients. azathioprine. Moderate rejection of ISHT
grade IlIA or IlIB was treated by bolus injection of methyl-
prednisone (l g/day for 3 days) and severe rejection (lSHT
grade IV) was treated with anti-Cm monoclonal antibody or
polyclonal antithymocyte globulin.
Results
Clinical data from the nine patients are summarized in
Table I. The 9 deaths represented 24% of the total number of
37 deaths in our group of transplant recipients.
Pathologic data (Table 2, Fig. 1and 2). All nine hearts had
>75% diffuse stenoses of proximal and distal epicardial
coronary arteries. No acute plaque change (intimal rupture
or hemorrhage) or coronary thrombi were noted. All lesions
were diffuse, concentric and uncomplicated, although one
heart (Case 9) showed focal calcification in an eccentric
arterial lesion. Intramyocardial arterial involvement was
seen in Cases 1, 2 and 8, although its presence was incon-
sistent in different regions of a single section.
Myocardial pathologic changes due to recent or ongoing
ischemia were noted in all nine hearts examined. Lesions
included subendocardial myocyte vacuolization (seven
hearts) and microscopic foci of regional coagulation necrosis
and granulation tissue or scar, or both (seven hearts). Five of
the nine hearts had myocardial changes characteristic of
graft arteriosclerosis at prior endomyocardial biopsy.
Focal or diffuse subendocardial myocyte vacuolization
was present in seven cases. Vacuolization varied from
scanty isolated clusters of myocytes with partial central
cytoplasmic rarefaction (l +), to larger regions of affected
myocytes with definite cytoplasmic spaces (2+), to diffuse,
confluent areas with many severely affected cells (3+).
Consistently associated with periinfarct regions, suben-
docardial myocyte vacuolization (mild to severe) was also
seen in the absence of or distant from coagulation necrosis
(Cases 6 and 7) (Fig. IA). The mildest end of the spectrum of
injury is illustrated in the heart of an asymptomatic patient
(Case 6) with severe vascular obstructions, who experienced
protamine-induced anaphylaxis during yearly surveillance
angiography. Myocardial pathologic changes were limited to
mild subendocardial myocyte vacuolization in the left ven-
tricle. Vacuolization was present in the right ventricular
aspect of the septal subendocardium in four cases accessible
to endomyocardial biopsy, although its presence was more
consistent (seven cases) and distribution wider in the left
ventricular subendocardium. In two patients (Cases 2and 9),
an antemortem diagnosis of graft arteriosclerosis was made
by the presence of subendocardial myocyte vacuolization in
an endomyocardial biopsy specimen (Fig. lB and 2A and B).
In some cases, myocardial necrosis and healing were
analogous to those seen in chronic ischemic lesions second-
ary to typical atherosclerosis. However. acute lesions were
frequently very small «500 JLm), suggesting small vessel
obstruction, and healing appeared depressed, with foci of
"mummified" myocardium virtually devoid of inflammatory
cells frequently noted (Fig. IC). Healing lesions often had
fragmented myocytes scattered within advanced granulation
tissue, suggesting impaired removal of necrotic material.
Patchy microfocal areas of acute and healing myocardial
infarction were seen in seven cases; in these, ischemic
lesions were predominantly subendocardial, bilateral and
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Table 1. Clinical Data From Nine Patients
Major
Case Age (yr)*1 Postoperative Rejection Recipient Donor Lesions Demonstrated
No. Gender Interval (mo)t Symptoms Immunosuppression (mo):j: CMV§ CMV by Angiography Outcome
60/M 6 SOB CPA + Reoperation, alive
28 mo later
2 58/F 8 SOB, atrial CPA + Death
fibrillation
3 58/M 8 SOB, chest pain CPA + + Death
4 43/M 10 SOB CP 7 + + Death
5 40/M 10 Cardiac arrest CPA 4 + ND Death
6 50/M 12 Anaphylactic CPA 1;2 + + Death
reaction to
protamine
7 351M 46 Sudden death after CPA 0.5-2 NK + + Death
angiography
8 57/F 55 SOB CP I: 6 + Death
9 351M 59 SOB CPA 2.5-5: + + Death
7-10; 15
*Age at cardiac transplantation. tInterval between transplantation and death or reoperation. +Time (duration if prolonged) of treated rejection episodes.
§Cytomegalovirus (CMV) status at transplantation. CP = cyclosporine A and prednisone; CPA = cyclosporine A. prednisone and azathioprine: F =female: M
= male: ND = not done; NK = not known; SOB = shortness of breath; + = present; - = absent.
microscopic, although focal transmural extension (Case 2),
sparing of the right ventricle (Cases 7 and 8) and macroscop-
ically visible injury (Case 2) were noted. Four hearts had
predominant areas of acute necrosis and healing granulation
tissue and three had older lesions composed of organizing
granulation tissue and replacement fibrosis. The subendocar-
dial component of small infarcts often had an approximately
IOO-Jlm rim of preserved, immediately subendocardial myo-
cardium that probably received perfusion from the left
ventricular chamber (Fig. lD). Although active acute myo-
cardial rejection was noted in several endomyocardial bi-
opsy specimens and was present in one heart at autopsy
(Case 3), the presence of rejection with its distinct morpho-
logic features did not confound the recognition of graft
arteriosclerosis-related ischemic lesions.
A transmural regional infarct occurred in Case 4 (Fig.
IE). This patient had marked intimal proliferation superim-
posed on a subcritical native atherosclerotic lesion in the left
anterior descending artery, resulting in critical stenosis. The
diagnosis of graft arteriosclerosis was made antemortem by
the presence of coagulation necrosis on endomyocardial
biopsy.
Case 9 exemplifies the concurrent presence of several
characteristic myocardial lesions, as well as left- and right-
sided and biopsy-autopsy correlations (Fig. 2). More than 5
years after transplantation, this patient had three-vessel graft
arteriosclerosis demonstrated angiographically; he died of
progressive congestive heart failure. Seventeen days before
death, ischemic injury including microfocal coagulation ne-
crosis and severe subendocardial myocyte vacuolization
(Fig. 2, A and D) was observed in both right- and left-sided
endomyocardial biopsy specimens. The right and left ven-
tricular myocardium examined at autopsy also had these
findings along with multiple, patchy small areas of acute and
healing infarction (Fig. 2, D and E).
Discussion
Graft arteriosclerosis. This is characterized by intimal
proliferation of smooth muscle cells with extensive connec-
tive tissue deposition and variable chronic inflammatory cell
infiltrates (2,3,6). Development of the lesion does not con-
sistently correlate with age, gender, degree of donor-
recipient HLA mismatch, etiology of pretransplant cardio-
myopathy, previous myocardial rejection episodes or serum
lipid variables (12). The mechanism of formation of graft
atherosclerosis is uncertain, although it is generally assumed
that proliferative vascular changes are probably the result of
previous, possibly repetitive or continuous cell-mediated or
humoral immunologic damage to the intima followed by
intimal proliferation (3,13-15). It has been suggested that
cytomegalovirus infection may result in the acceleration or
accentuation of this process (16). The time interval from
transplantation to the appearance of graft arteriosclerosis is
highly variable. That six of the nine cases reported here
occurred <1 year after operation serves to illustrate the
rapidity with which graft arteriosclerosis can develop.
Myocardial pathologic changes associated with graft arte-
riosclerosis. Our nine hearts with severe graft arteriosclero-
sis demonstrate a spectrum of myocardial injury resulting
from progressive narrowing of the coronary arteries, vascu-
lar insufficiency and ischemia. We hypothesized that the
earliest myocardial change could be a reversible ischemic
change in myocardial watershed zones, possibly manifested
by subendocardial myocyte vacuolization. This lesion is a
well described feature of severe native ischemic heart dis-
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Table 2. Pathologic Data in Nine Cases
Autopsy
Coronary OcclusIOn
Case Endomyocardial Biopsy Epicardial Intramyocardial Degree of SEMV
No. (days before death) (>75%) (>50%) (right/left) Other Myocardial Injury
Healing injury (9); Present Present ttt/ttt Small patchy acute and healing infarcts, RV
NEI (42); and LV
NEI (2 mol
2 SEMV (17); Present Present -/tt Large patchy acute and healing infarcts,
NEI (20); LV and RV
NEI (31), ISHT II
CN (45); Present Absent -/- Large posteroseptal healing infarct, small
NEI (51); patchy older healing infarcts and scar,
NEI (67), ISHT IA RV and LV; rejection approximately
ISHT level IIA-I1I (lSHT grading not
formulated for whole heart sections)
4 CN (9) (left); Present Absent t/tt Transmural acute infarct, anteroseptal LV
NEI (12), ISHT IA;
NEI (23)
5 NEI (3), ISHT II; Present Absent -/- Small patchy older healing infarcts and
NEI (42) ISHT IA; scar, LV and RV
NEI (3 mol, ISHT II
6 NEI (46); Present Absent -/t None
NEI (3 mol;
NEI (3 mol
7 NEI (5); Present Absent ttt/ttt Small patchy healing infarcts and scar, LV
NEI(9);
NEI (28), ISHT IlIA
8 NEI (4+ mol, ISHT II Present Present -/ttt Large subendocardial acute infarct, LV
CN (\30);
NEI (6 mol
9 SEMV, CN (\2) (left t right); Present Absent t/ttt Small patchy acute and healing infarcts,
NEI (19); LV and RV
NEI (5 mol
Acute rejection is classified according to International Society for Heart Transplantation (ISHTj grade; right ventricular biopsy and no evidence of rejection
unless otherwise indicated. CN =coagulation necrosis; LV =left ventricle; NEI = no evidence of ischemic injury; RV =right ventricle; SEMV =subendocardial
myocyte vacuolization; t = mild, t t = moderate; t t t = severe; - = absent (see text).
ease found in relatively poorly perfused subendocardium or
at infarct margins (0). Clinical and immunohistochemical
evidence (17,18) suggests that subendocardial myocyte vac-
uolization can be reversed if sufficient myocardial blood flow
is restored. In seven of our cases, a more advanced pattern
of injury with myocardial infarcts or microinfarcts was
observed. In some cases, microscopic areas of recent necro-
sis and myocardium in various stages of healing were noted
in the same specimen. Microinfarcts were noted to be
healing poorly in most cases, consistent with the immuno-
suppressive and anti-inflammatory drug therapy used to
manage these patients.
A large acute regional infarct occurred in one patient
whose proximal left anterior descending coronary artery was
severely and focally narrowed by graft arteriosclerosis over-
lying a typical atherosclerotic plaque that was undoubtedly
present in the donor heart at the time of transplantation.
Although no pathogenetic link is postulated, this case em-
phasizes that the effect of progressive graft arteriosclerosis
can be amplified by subcritical stenosis of a large epicardial
vessel present at the time of transplantation (3).
Clinical implications. Because graft arteriosclerosis re-
mains a difficult problem in clinical management, the char-
acteristic pathologic findings have several implications.
Myocardial pathologic changes due to graft arteriosclerosis
were noted in all nine hearts and characteristic lesions
permitted the diagnosis at biopsy in five patients. Thus,
evidence of these lesions should be aggressively sought at
biopsy in patients in whom the diagnosis of graft arterioscle-
rosis is considered because of clinical symptoms or long
postoperative interval. Clinical and angiographic diagnosis is
otherwise difficult and intimal proliferation may become
hemodynamically and clinically significant in small distal
penetrating arteries before the large epicardial vessels are
affected, as illustrated by the presence of severe vascular
disease in the setting of normal coronary angiographic
findings (Cases 2 and 8). The diffuse lesions extending along
the entire length of the vessel are generally not amenable to
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Figure 1. The spectrum of myocardial changes in graft arterioscle-
rosis. A, Case 7. Subendocardial myocyte vacuolization noted at
autopsy. B, Case 2. Subendocardial myocyte vacuolization noted at
right ventricular endomyocardial biopsy shortly before death. C,
Case 1. Poorly healing myocardial microinfarct (arrow) noted at
reoperation. D, Case 7. Granulation tissue (asterisk) noted at au-
topsy. Note the rim of approximately 100 ~m of preserved suben-
docardial myocardium, with mild subendocardial myocyte vacu-
olization (between arrows) that probably receives perfusion from the
left ventricular chamber. E, Case 4. Acute coagulation necrosis
(arrow) adjacent to evolving replacement fibrosis (granulation tis-
sue) noted at autopsy. A, B, D and E, Hematoxylin-eosin stain; C,
Masson's trichrome stain. Magnification: A, Dand Ex 140, B x 175,
C x 120; all reduced by 5%.
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Figure 2. Case 9. Myocardial pathologic changes due to graft
arteriosclerosis, demonstrating correlations between left- and right-
sided and biopsy and autopsy findings. A, Subendocardial myocyte
vacuolization noted at right ventricular biopsy (arrow). B, Suben-
docardial myocyte vacuolization present at autopsy in a section
taken from the right ventricle (arrow). C, Large area of coagulation
necrosis (asterisk). The only area of viable myocardium is denoted
by the arrow in the upper left. D, Prominent subendocardial myo-
cyte vacuolization noted at left ventricular biopsy. E, Healing
coagulation necrosis with early granulation tissue (asterisk) and
viable rim of subendocardial myocytes with prominent subendocar-
dial myocyte vacuolization (arrow) in a left ventricular section at
autopsy. These biopsy specimens were taken 17 days before death;
the presence of fragmented myocytes in the healing lesions that
were noted to be acute 17 days previously suggests delayed healing.
A to E, Hematoxylin-eosin stain. Magnification: A to D x375; E
x325; all reduced by 5%.
592 NEISH ET AL.
MYOCARDIUM IN GRAFT ARTERIOSCLEROSIS
lAce Vol. 19, No.3
March 1, 1992'586-92
coronary bypass surgery or percutaneous angioplasty. The
only widely effective therapy is retransplantation (19). As
with typical atherosclerotic coronary obstructions, the clin-
ical effects of obstructive graft arteriosclerosis could be
precipitated or exacerbated, or both, by physiologic com-
promise of myocardial oxygen requirements caused by ex-
ertion or hypotensive or hypovolemic states.
Conclusions. Our study suggests that endomyocardial
biopsy may reveal graft arteriosclerosis-associated myocar-
dial ischemic injury in many cases. Subendocardial myocyte
vacuolization and microinfarcts are common in severe graft
arteriosclerosis and occur in areas accessible to endomyo-
cardial biopsy. Although subendocardial myocyte vacuoliza-
tion may be transient and patchy, leading to potential
sampling error, its presence in an endomyocardial biopsy
sample indicates severe ischemia and should strongly sug-
gest the diagnosis of graft arteriosclerosis.
We thank the members of the Brigham and Women's Hospital Cardiac
Transplant Service for their efforts in the clinical management of the patients
reported in this study.
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